What Executives Should Really Expect from Ergonomics Reporting

Blog by: Bryan Statham, CEO at LifeBooster

 

Why modern ergonomics reporting must move beyond assessments and recommendations to help leaders understand risk, prioritize spend, validate ROI, and govern workforce performance with confidence.

Most ergonomics reporting still answers the wrong questions.

It tells you which jobs were assessed, which tasks were flagged, and which recommendations were made. That is useful for practitioners, but it is not what executives, operating leaders, or boards need for effective decision making.

Senior leadership does not need another technical report. They need a clearer view of where workforce risk is building, what it is likely to cost, where to invest first, and whether those investments are actually working. They need reporting that functions as part of a broader safety performance and governance system, not a 200-page PDF that gets filed after a site visit and never influences a capital decision.

For most organizations, that gap is wider than it should be. Ergonomics data still lives too close to the task level and too far from the business. It describes issues but does not quantify financial exposure. It recommends changes but never validates whether money spent created measurable improvement. It surfaces risk but does not show how that risk is trending across sites, functions, and business units, or how it should influence executive priorities.

The stakes are not abstract. In the U.S., overexertion involving outside sources has remained the leading cause of the most serious workplace injuries for 25 straight years, with an estimated annual cost of $13.7 billion¹. Washington State data shows that work-related musculoskeletal disorders account for roughly one-third of wage-replacement and disability claim costs and tend to have longer time-loss duration than other claim types². And recent research from the NSC MSD Solutions Lab found that 70% of frontline workers surveyed reported MSD symptoms, with 64% having missed work as a result³.

That is why the standard for ergonomics reporting needs to change. It should no longer be treated as a technical output, but as part of how an organization understands exposure, governs risk, prioritizes capital, and validates operational improvement.

 

What Executives Should Actually Expect

A stronger reporting model should help leadership answer six practical questions with confidence.

 

1. Where are we carrying the greatest exposure, and why does it matter?

Executives should be able to see where cumulative physical risk is concentrated across the organization, whether by site, business unit, region, role, or process. But that view must go beyond a list of high-risk jobs. It needs to show where exposure is material to the business.

That means identifying not just severity, but scale and consequence. Which risks affect the largest number of workers? Which sit inside operationally critical workflows? Which are tied to recurring strain, absenteeism, turnover, quality variation, or production instability? Which exposures are being absorbed by the workforce today but have not yet surfaced in lagging injury data?

This is what makes reporting useful at the leadership level. It turns isolated ergonomic findings into a clearer view of exposure burden and business relevance.

 

2. Are we reducing risk without creating a productivity penalty?

This question deserves early attention because it sits at the center of why many executives hesitate to act on safety-driven recommendations in the first place.

Operations leaders are often wary that ergonomic interventions will slow work down, reduce output, or add friction. A modern reporting model should help management move beyond that false tradeoff. It should show where risk reduction and operational performance can improve together, where tradeoffs are real, and which intervention options create the best balance.

If safety is going to be taken seriously in capital allocation conversations, reporting has to speak the language of throughput, labor stability, and efficiency, not just hazard identification.

 

3. What is this risk going to cost us if we do nothing?

Most ergonomics reporting does not frame the cost of inaction in a way that supports budget decisions. That is its most consequential weakness.

Executives are expected to allocate resources across competing priorities, and they evaluate those decisions through a financial and operational lens. A more useful reporting model should help leadership understand the likely cost associated with unresolved exposure, including injury and claims cost, absenteeism, overtime, temporary labor, turnover, reduced throughput, fatigue-driven inefficiency, and quality issues.

Those costs do not sit in one section of the financial statements. They show up across the income statement as:

• Higher cost of goods sold from reduced manufacturing efficiency
• Increased operating expenses from medical costs and replacement labor
• Rising insurance premiums
• Lost revenue from missed production targets

They show up on the balance sheet as:

• Growing insurance reserves
• Reduced asset productivity

They show up in cash flow statements as:

• Reduced operating cash flow
• Higher borrowing costs tied to weaker credit ratings (publicly traded companies)

When ergonomics reporting cannot connect exposure to these financial realities, it is almost impossible for leadership to prioritize it alongside other capital demands.

The quality dimension is especially underappreciated. Research suggests that roughly 40% of quality defects in manufacturing environments are attributable to the mental and physical fatigue of difficult work⁴. Research on the full cost of workplace injuries consistently shows that indirect and organizational costs, including quality failures, process instability, productivity loss, and turnover, significantly exceed the direct injury and claims costs that most organizations track. Estimates of the ratio vary but the pattern is clear: the costs visible to EHS are only a fraction of the total burden the business absorbs. That makes unresolved ergonomic risk one of the largest hidden cost drivers in labor-intensive operations.

The goal is not false precision. The goal is a credible estimate of business exposure so that ergonomic risk can be evaluated alongside other operational risks and investment opportunities.

There is a good reason this matters. Washington State data shows that median wage-replacement and disability costs for MSD claims are higher than for other claim types, and median time-loss duration is longer². The cost burden extends well beyond the initial injury. It includes how long the worker is away, how difficult the return-to-work process becomes, and how much disruption the business absorbs in the meantime. Research has also found that injured workers have higher odds of being treated for depression after occupational injury⁵, and that anxiety or depression can negatively affect sustained return to work⁶. When an ergonomic injury becomes a longer, more complex recovery, the cost to the employer expands through disability management, delayed return to work, and broader workforce disruption.

 

4. What should we invest in first, and what are we buying?

Not every problem deserves the same urgency, and not every high-risk task should receive the same investment.

Executives need reporting that supports prioritization by combining exposure severity with workforce reach, operational criticality, likely cost of inaction, and estimated cost to intervene. A job may score as high risk, but if it affects relatively few people and sits outside a critical workflow, it may not be the highest-value place to act first. Another issue may be moderate-to-high risk, but affects hundreds of workers across multiple sites inside a key operating process. That becomes a much more important executive priority.

This extends to the spend side. If management is considering a redesign, a tooling change, a workstation upgrade, or an assistive technology investment, leadership should be able to assess the likely implementation cost, deployment scale, rollout complexity, and expected performance benefit. Is this a low-cost, high-impact fix? Is it a larger spend with meaningful cross-site potential? Does the likely exposure reduction justify the cost? Does the intervention also improve consistency, productivity, or labor sustainability?

That is the level of decision support executives need before approving action.

 

5. Did the money we spent actually work?

This is where credibility is won.

Too many ergonomics programs end at recommendation. An issue is assessed, a change is proposed, and an intervention is installed. But for executive leaders, that is only halfway through the process. They want validation.

They want to know:

• Whether exposure levels declined after the change
• Whether the improvement was sustained
• Whether similar jobs or sites benefited
• Whether productivity was preserved or improved
• Whether downstream costs or operational friction were reduced

In other words, they want to know whether the investment produced measurable value, and whether successful interventions should be scaled across additional sites, roles, or business units.

That changes ergonomics from a recommendation engine into a measurable performance function. Without that validation loop, successful programs often face a perverse outcome: they reduce injuries and costs, and then have their resources cut because the problem appears solved. If the only metrics a program reports are injury rates and claims costs, success can look like the problem going away. Reporting that connects to broader operational performance protects against that dynamic and gives leadership the evidence they need to sustain and scale what is working.

 

6. What is the return on intervention?

Executives need a credible business case, not perfect ROI math.

A stronger reporting model should help estimate return in practical terms: avoided injury-related cost, reduced strain in high-concentration roles, fewer disruption events tied to fatigue or discomfort, improved labor stability, more consistent output, and stronger justification for scaling successful interventions.

In some cases, return shows up in direct financial savings. In others, it shows up in reduced risk, improved resilience, and stronger operational consistency. Both matter. What executives need is a framework for understanding the value created relative to the money spent.

Without that framework, ergonomics budgets are treated as discretionary. With it, ergonomic intervention becomes a justifiable operating investment.

 

What the Board Should Expect

Board members do not need ergonomic detail. They need confidence in the decisions they are making.

That means evidence that management has a credible system for identifying where workforce exposure risk is building, whether that risk is increasing or decreasing, where improvement dollars are being directed, and whether those investments are producing measurable reduction in risk and business exposure.

Boards increasingly expect management teams to govern proactively, not reactively. They want confidence that leadership is not relying solely on incident rates, recordables, or claims data to understand safety performance. They want to see that management can detect emerging issues early, prioritize action intelligently, and connect workforce risk to broader organizational resilience.

There is also a growing body of evidence that workforce safety performance connects to financial market outcomes. In a 2022 analysis, S&P Global Ratings has reported that ESG factors influenced roughly one in four potential credit downgrades, with social factors, including health and safety and human capital management as the primary drivers⁷. These potential downgrades were more than twice as likely to result in an actual downgrade compared to the broader portfolio. And the financial consequences of a downgrade are well documented: peer-reviewed research consistently finds that credit rating downgrades are associated with stock price declines in the range of 3% to 7% around the announcement⁸⁻⁹. That gives boards a direct reason to ask whether management has adequate visibility into workforce exposure risk and whether that risk is being governed with the same rigor applied to other enterprise risks.

Workforce exposure risk should connect to the priorities and risks the organization already discloses in its annual filings. For publicly traded companies, the SEC Form 10-K identifies strategic priorities and risk factors that shape capital allocation and investor confidence. If ergonomics reporting cannot connect to those disclosed priorities, it will remain invisible at the governance level.

In practice, that means a board should be able to review a quarterly safety performance summary that shows enterprise-wide exposure trends, site-by-site risk concentration, intervention spend and outcomes, leading indicator movement alongside lagging metrics, and clear evidence that the risk profile is improving. Or an explanation of why it is not and what management is doing about it. That is a fundamentally different standard than a slide showing TRIR and a list of completed corrective actions.

This expectation is especially strong in labor-intensive and operationally complex environments, where human performance and operational performance are tightly linked. In those settings, ergonomics reporting is not a narrow safety activity. It is part of enterprise risk oversight.

 

The New Executive Standard

The true standard for ergonomics reporting is the value it brings to decisions, not the volume of detail it contains.

Instead of answering what did we assess?, it should help answer what should we do, what will it cost, and did it work?

Executives should expect reporting that helps them see risk earlier, direct resources more effectively, validate spend, and understand where human risk is quietly creating financial and operational exposure inside the business. Boards should expect management to have this capability, because once ergonomics data is structured properly, it stops being a specialist report and becomes a leadership tool for governing safety performance and making smarter business decisions.

That is where the market is headed. And it is where executive expectations should be now.

If you want to see what executive-grade safety performance reporting looks like in practice, we would welcome the conversation.

 

References

1. Liberty Mutual Insurance. 2025 Workplace Safety Index. Published July 2025. https://business.libertymutual.com/workplace-safety-index/
2. Washington State Department of Labor and Industries, Safety & Health Assessment & Research for Prevention (SHARP). Work-Related Musculoskeletal Disorders of the Back, Upper Extremity, and Knee in Washington State, 2006–2019. (2022 Surveillance Report). https://www.lni.wa.gov/safety-health/safety-research/files/2022/99_06_2022_WMSD_SurveillanceReport.pdf
3. National Safety Council, MSD Solutions Lab. Frontline Worker Perceptions of MSD Prevention Technology. Published April 2026. https://www.nsc.org/msd
4. Kolus, A., Wells, R., and Neumann, W.P. (2018). “Examining the fatigue-quality relationship in manufacturing.” Applied Ergonomics, 74, 1–7. https://pubmed.ncbi.nlm.nih.gov/31450046/
5. Kim, J. (2013). “Depression as a psychosocial consequence of occupational injury in the US working population: findings from the medical expenditure panel survey.” BMC Public Health, 13, 303. https://bmcpublichealth.biomedcentral.com/articles/10.1186/1471-2458-13-303
6. Jones, A.M., Koehoorn, M., Bültmann, U., and McLeod, C.B. (2021). “Impact of anxiety and depression disorders on sustained return to work after work-related musculoskeletal strain or sprain: a gender-stratified cohort study.” Scandinavian Journal of Work, Environment & Health, 47(4), 296–305. https://pubmed.ncbi.nlm.nih.gov/33744976/
7. S&P Global Ratings. “Credit Trends: ESG Factors Influence Close To 1 In 4 Potential Downgrades As 2022 Unfolds.” February 3, 2022. https://www.spglobal.com/ratings/en/research/articles/220203-credit-trends-esg-factors-influence-close-to-1-in-4-potential-downgrades-as-2022-unfolds-12262601
8. Chava, S., Ganduri, C., and Ornthanalai, C. (2019). “What moves stock prices around credit rating changes?” Review of Accounting Studies, 26, 1390–1427. https://link.springer.com/article/10.1007/s11142-020-09573-6
9. Jorion, P., Liu, Z., and Shi, C. (2005). “Informational effects of regulation FD: evidence from rating agencies.” Journal of Financial Economics, 76(2), 309–330.